NYSE:LHHealthcare
Labcorp’s Expanded Receivables Facility: What Does LH’s Liquidity Move Signal About Its Capital Strategy?
Labcorp Holdings recently executed a second amendment to its receivables purchase agreement, extending the facility’s termination date to January 26, 2029 and adding an accordion feature that can lift its size from US$700 million to US$825 million.
This extension and potential expansion of receivables financing gives Labcorp additional liquidity flexibility while keeping the structure separate from traditional on-balance-sheet borrowing.
With this expanded receivables facility enhancing...